Evaluation of USP 3 Apparatus to Develop Biopredictive Fasted and Fed Dissolution Methods for Extended-Release Desvenlafaxine Succinate Tablets
Open Access
- 19 February 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (8) , 13572-13580
Abstract
The development of distinct biopredictive methods for fasted and fed states using a physiologically based biopharmaceutics modeling (PBBM) approach is essential for accurately evaluating drug release from solid oral dosage forms, especially extended-release products. However, a fed state biopredictive method for desvenlafaxine tablets is not currently available. Hence, the study aimed to investigate the application of the USP 3 apparatus to develop biopredictive methods for desvenlafaxine tablets. Initially, an existing fasted state biopredictive USP 2 dissolution method was adapted to increase dissolution hydrodynamics by scaling the rotation speed to 75 and 100 rotations per minute (rpm). Subsequently, two dissolution methods were developed using the USP 3 apparatus to emulate fasted and fed conditions. The fed biopredictability of the methods was assessed using a previously developed GastroPlus model to simulate fed conditions under 800 kcal and 50% fat meal. Statistical analysis of dissolution profiles obtained in the paddle apparatus revealed no significant difference from the original 50 rpm method and lacked biopredictive for the fed state, indicating the unfeasibility of developing such a method in this apparatus. In contrast, USP 3 proved to be an important tool to develop a fed state method, since it was biopredictable based on simulation analysis. Additionally, no significant differences were observed between USP 3 methods employing pH-gradient media and those using 0.9% NaCl as the sole medium. These findings highlight a hydrodynamic-driven approach for applying USP 3 to develop distinct biopredictive dissolution methods for fasted and fed states, particularly for high-solubility drugs formulated in robust hypromellose matrices.Keywords
Funding Information
- Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (001)
- Faculdade de Ci?ncias Farmac?uticas, Universidade de S?o Paulo (22.1.00142.09.7)
- Faculdade de Ci?ncias Farmac?uticas, Universidade de S?o Paulo (331/2025I)
This publication has 34 references indexed in Scilit:
- Kinetic Modeling to Explain the Release of Medicine from Drug Delivery SystemsChemBioEng Reviews, 2023
- Patient-specific in vitro drug release testing coupled with in silico PBPK modeling to forecast the in vivo performance of oral extended-release levodopa formulations in Parkinson’s disease patientsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2022
- Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic DrugsPharmaceutical Research, 2022
- Dissolution testing of modified release products with biorelevant media: An OrBiTo ring study using the USP apparatus III and IVEuropean Journal of Pharmaceutics and Biopharmaceutics, 2020
- Modeling and comparison of release profiles: Effect of the dissolution methodEuropean Journal of Pharmaceutical Sciences, 2017
- Velocity Field Visualization in USP Dissolution Apparatus 3 Using Particle Image VelocimetryPharmaceutical Research, 2017
- Development and Qualification of Physiologically Based Pharmacokinetic Models for Drugs With Atypical Distribution Behavior: A Desipramine Case StudyCPT: Pharmacometrics & Systems Pharmacology, 2017
- In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulationEuropean Journal of Pharmaceutical Sciences, 2015
- The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matricesColloids and Surfaces B: Biointerfaces, 2013
- Release characterization of dimenhydrinate from an eroding and swelling matrix: selection of appropriate dissolution apparatusInternational Journal of Pharmaceutics, 2005